Research

This month’s Healer webinar provided a deep dive into six studies on cannabis for various conditions.

Given the fast and furious mobilization of the global healthcare community to understand the nature of the coronavirus, how to treat it, and, eventually, how to prevent it, the sheer volume of research on COVID-19 is not at all surprising. What is, perhaps, surprising, especially given how recently it’s been since the COVID-19 breakout, is that there are so many research publications on the potential for cannabis to be used to treat the virus. On the other hand, perhaps the abundance of research on cannabis for COVID-19 is not so surprising. After all, it is a virus that causes an immune response, which may escalate into a virulent inflammatory reaction. And an enormous body of research on cannabis—and cannabidiol (CBD) in particular—has shown cannabis to induce strong anti-viral and anti-inflammatory effects. It is still early days, so no clinical studies establishing the efficacy of cannabis for COVID-19 have yet been conducted, but studies have established several clear mechanisms of action for using cannabis to treat COVID-19.

Drs. Allison Justice and Riley Kirk share a preview of their research project that will be presented at Cannabis Science Conference Spring 2024.

Keynote presenters Drs. Allison Justice and Riley Kirk share how they have seen women effect change in the cannabis industry.

This article provides insights on the latest findings from academic researchers exploring the impacts of emerging technology on hemp grown for cannabidiol (CBD).

This article explains four key areas growers should focus on to mitigate the need for excessive remediation.

As markets mature, manufacturing terpene blends have become a new art form and a differentiating factor for potential therapeutic applications. Here, we dive deeper into the insights of terpene formulation considerations.

Clinically significant reductions in symptoms were reported.

Prior research has established the role of cannabis in fighting cancer and this study aimed to see how exactly it works in melanoma.

In this blog installment, we take a deep dive into research on how cannabis affects neurodegenerative disorders such as Alzheimer’s disease, multiple sclerosis, and Parkinson’s disease.

A recently published national survey collected data on cannabis use for pets.

A cannabis-based treatment was shown to be effective for cognitive disfunctions.

Healer’s first webinar of the year provided a research update on studies examining cannabis used as a treatment for different neurologic conditions.

A new study involving veterans reported beneficial effects of ibogaine as a therapeutic treatment.

In this article, we dive deeper into the physical, cellular, and molecular adaptions that plants demonstrate in response to light intensity and spectrum.

A recent study tested the safety and efficacy of cannabidiol in relieving emergency dental pain.

Researchers analyzed several bone samples from a hospital crypt and detected two cannabinoids.

A study of a small sample of young adults compared cannabis, alcohol, and cigarette use before and after recreational cannabis became legal.

A study involving cannabigerol (CBG) injections in mice tested the effectiveness in pain reduction.

An upcoming clinical trial will test a unique CBD treatment for Autism Spectrum Disorder symptoms in children.

The study resulted in several findings on cannabis use and connections to physical and mental health conditions.

This blog installment looks at the use of cannabis for pets. Topics covered include the history of cannabis use in veterinary medicine, current laws on cannabis for pets, market size and segment, reported experiences from both pet owners and veterinarians, and pet toxicology.

The University of Buffalo has received a grant from the NIH National Cancer Institute to research cannabis’s medicinal effect on cancer immunotherapy treatment.

Our sister publication, Nutritional Outlook, recently published an article about how hair health could turn into another promising market for CBD.

A survey conducted by EO Care, Inc., showed that Americans would be more inclined to use cannabis to treat their health conditions if they were guided by a clinician.